Barbouche M R, Guilbert B, Makni S, Gorgi Y, Ayed K, Avrameas S
Unité d'Immunocytochimie, CNRS URA 359, Institut Pasteur, Paris, France.
Clin Exp Immunol. 1993 Feb;91(2):196-201. doi: 10.1111/j.1365-2249.1993.tb05882.x.
Several human monoclonal immunoglobulins with the same autoantibody activity have been shown to have cross-reactive idiotypes (CRI). In this study, using polyclonal anti-idiotypic antibodies, we found that 28% of human monoclonal immunoglobulins with polyreactive autoantibody activity from myeloma, Waldenström's macroglobulinaemia and cryoglobulinaemia patients shared common idiotype(s). Furthermore, the latter were expressed on human and murine natural MoAbs (respectively in 12% and 22% of the clones tested) and on human IgG preparations used for therapeutic intravenous injections (IVIg) and which contain natural antibodies. These findings suggest that monoclonal immunoglobulins could arise from the proliferation of a clone that normally produces a natural antibody. The existence of common idiotype(s) between monoclonal immunoglobulins and IVIg could be relevant to the improvement noted after treatment with IVIg in patients suffering from peripheral neuropathies associated with monoclonal gammopathy.
几种具有相同自身抗体活性的人源单克隆免疫球蛋白已被证明具有交叉反应性独特型(CRI)。在本研究中,我们使用多克隆抗独特型抗体发现,来自骨髓瘤、华氏巨球蛋白血症和冷球蛋白血症患者的具有多反应性自身抗体活性的人源单克隆免疫球蛋白中有28%具有共同的独特型。此外,后者在人和鼠的天然单克隆抗体上表达(分别在所测试克隆的12%和22%中),以及在用于治疗性静脉注射(IVIg)且含有天然抗体的人IgG制剂上表达。这些发现表明,单克隆免疫球蛋白可能源自正常产生天然抗体的克隆的增殖。单克隆免疫球蛋白与IVIg之间共同独特型的存在可能与IVIg治疗患有与单克隆丙种球蛋白病相关的周围神经病患者后所观察到的病情改善有关。